193 related articles for article (PubMed ID: 27391369)
1. Gas1 up-regulation is inducible and contributes to cell apoptosis in reactive astrocytes in the substantia nigra of LPS and MPTP models.
Sun XL; Chen BY; Zhao HK; Cheng YY; Zheng MH; Duan L; Jiang W; Chen LW
J Neuroinflammation; 2016 Jul; 13(1):180. PubMed ID: 27391369
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
[TBL] [Abstract][Full Text] [Related]
3. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
4. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
Aoki E; Yano R; Yokoyama H; Kato H; Araki T
Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
[TBL] [Abstract][Full Text] [Related]
5. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes.
Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS
J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442
[TBL] [Abstract][Full Text] [Related]
6. Possible mechanisms of the protection of ginsenoside Re against MPTP-induced apoptosis in substantia nigra neurons of Parkinson's disease mouse model.
Xu BB; Liu CQ; Gao X; Zhang WQ; Wang SW; Cao YL
J Asian Nat Prod Res; 2005 Jun; 7(3):215-24. PubMed ID: 15621629
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
9. Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson's disease.
Kirkley KS; Popichak KA; Hammond SL; Davies C; Hunt L; Tjalkens RB
Neurobiol Dis; 2019 Jul; 127():193-209. PubMed ID: 30818064
[TBL] [Abstract][Full Text] [Related]
10. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K; Inada T; Shingu K
Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
[TBL] [Abstract][Full Text] [Related]
12. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
13. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
14. Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment of mice.
Hassouna I; Wickert H; Zimmermann M; Gillardon F
Neurosci Lett; 1996 Feb; 204(1-2):85-8. PubMed ID: 8929984
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons.
Chen XC; Chen Y; Zhu YG; Fang F; Chen LM
Acta Pharmacol Sin; 2002 Sep; 23(9):829-34. PubMed ID: 12230953
[TBL] [Abstract][Full Text] [Related]
16. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Cossetti C; D'Adamo P; Zardini E; Andreoni L; Ihekwaba AE; Serra PA; Franciotta D; Martino G; Pluchino S; Marchetti B
Neurobiol Dis; 2011 Feb; 41(2):508-27. PubMed ID: 21056667
[TBL] [Abstract][Full Text] [Related]
17. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism.
Park G; Park YJ; Yang HO; Oh MS
Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986
[TBL] [Abstract][Full Text] [Related]
18. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
[TBL] [Abstract][Full Text] [Related]
19. Significant up-regulation of nestin protein in the neostriatum of MPTP-treated mice. Are the striatal astrocytes regionally activated after systemic MPTP administration?
Chen LW; Wei LC; Qiu Y; Liu HL; Rao ZR; Ju G; Chan YS
Brain Res; 2002 Jan; 925(1):9-17. PubMed ID: 11755896
[TBL] [Abstract][Full Text] [Related]
20. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
Malagelada C; Ryu EJ; Biswas SC; Jackson-Lewis V; Greene LA
J Neurosci; 2006 Sep; 26(39):9996-10005. PubMed ID: 17005863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]